GLP-1 (Ozempic/Wegovy/Mounjaro) Hair Loss: What the New Research Actually Shows
A large 2026 BMJ study confirmed GLP-1 weight-loss drugs carry a real, measurable hair loss risk — but the absolute risk is smaller than the headline numbers suggest, and the mechanism is mostly reversible telogen effluvium from rapid weight loss, not permanent follicle damage.





